Meditech Spine’s Talos devices receive FDA clearance for use with allograft bone graft: 3 notes

Meditech Spine’s Talos interbody devices have received FDA clearance for use with allograft comprised of cancellous or corticocancellous bone graft.

Advertisement

Here are three notes:

 

1. Meditech’s interbody cervical and lumbar devices are indicated for use with autograft or allograft.

 

2. These devices include the Talos-P, Talos-T, Talos-A, Talos-L and both the Talos-C and Talos-C (HA) interbody implants.

 

3. Meditech Spine is a spinal implant company. It obtained its first FDA clearance in 2009.

 

More articles on devices:
Minimally invasive surgical instrument market forecast: 3 takeaways
joimax launches EndoLIF On-Cage, iLESSYS Delta interlaminar systems
Life Spine releases devices for expandable lateral interbody fusions

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.